The ultimate goal of the research on the orexin/hypocretin system is to develop effective therapeutic interventions for various disorders, such as sleep disorders, obesity, addiction, and anxiety [23,53,66,68,69,85,106,108,116,160,162,217,272,273,274,275]. The gene discussed is HCRT; the disease is obesity due to melanocortin 4 receptor deficiency.